Clinical Trial

Investigation of Respiratory Muscle Sarcopenia in Patients With Systemic Sclerosis

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 19, 2024 (before its estimated January 2, 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim of this study was to investigate respiratory muscle sarcopenia in individuals with systemic sclerosis. The main question it aims to answer is: What is the prevalence of respiratory muscle sarcopenia in patients with systemic sclerosis? Participants body composition (bioelectrical impedance), hand grip strength (hand dynanometer), physical performance tests (5 repetition sit-and-stand test, 4-meter walk test, Timed up-and-go test) and respiratory muscle strength were evaluated.
Trial Details
NCT Number NCT06598982
Lead Sponsor Selcuk University
Conditions Systemic Sclerosis (SSc), Scleroderma
Enrollment 85 participants
Start Date 2024-07-01
Primary Completion 2025-01-02 (estimated)
Study Completion 2025-07-01 (estimated)
Updated on ClinicalTrials.gov 2024-09-19